{{Rsnum
|rsid=1893220
|Gene=MC2R
|Chromosome=18
|position=13916295
|Orientation=minus
|GMAF=0.3108
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=MC2R
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 18.8 | 54.7 | 26.6
| HCB | 0.0 | 26.7 | 73.3
| JPT | 4.4 | 55.6 | 40.0
| YRI | 8.2 | 26.2 | 65.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 26.7 | 73.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID|19024088}} [[rs1893220]] and [[rs2186944]] efficacy of ACTH therapy on infantile spasms.

{{PMID Auto
|PMID=20042918
|Title=ACTH receptor (MC2R) promoter variants associated with infantile spasms modulate MC2R expression and responsiveness to ACTH
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}